ARTA
SLDB icon

A.R.T. Advisors’s Solid Biosciences SLDB Stock Holding History

A.R.T. Advisors’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-4,308
Closed -$288K – 839
2019
Q4 		$288K Buy
+4,308
New +$475K 0.01% 1038
2019
Q3 		– Sell
-4,970
Closed -$429K – 1704
2019
Q2 		$429K Sell
4,970
-52
-1% -$5.67K 0.02% 809
2019
Q1 		$693K Buy
5,022
+2,973
+145% +$745K 0.04% 623
2018
Q4 		$824K Buy
2,049
+505
+33% +$237K 0.05% 512
2018
Q3 		$1.09M Buy
+1,544
New +$970K 0.05% 545

Other funds holding SLDB

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

A.R.T. Advisors's SLDB Position: Q1 2020 in Review

A.R.T. Advisors sold out of Solid Biosciences (SLDB) in Q1 2020, closing a stake of 4,308 shares — an estimated $288K sold.

A.R.T. Advisors first reported a position in SLDB in Q3 2018 and held it in 5 quarters. The position peaked at $1.09M in Q3 2018. 71 funds tracked by Wall St. Rank hold SLDB as of Q1 2020.

  • A.R.T. Advisors reported no remaining Solid Biosciences position as of Q1 2020 after selling out during the quarter.
  • A.R.T. Advisors sold 4,308 Solid Biosciences shares in Q1 2020, an estimated $288K.
  • A.R.T. Advisors first reported a position in Solid Biosciences in Q3 2018 and held it in 5 quarters.
  • A.R.T. Advisors's Solid Biosciences position peaked at $1.09M in Q3 2018.
  • 71 funds tracked by Wall St. Rank held Solid Biosciences as of Q1 2020.

Based on A.R.T. Advisors's 13F filing for Q1 2020, filed 15 May 2020.